In an adult patient with supraventricular tachycardia (SVT), when is cardioversion indicated and what are the recommended synchronized shock energy settings and sedation regimen?

Cardioversion in SVT

Synchronized cardioversion is indicated immediately for hemodynamically unstable SVT (hypotension, altered mental status, shock, chest pain, acute heart failure) when vagal maneuvers or adenosine fail or are not feasible; for stable patients, cardioversion is reserved for cases where pharmacological therapy is ineffective or contraindicated. 1

Indications for Cardioversion

Hemodynamically Unstable Patients

Cardioversion should be performed early in patients presenting with:

• Hypotension
• Acutely altered mental status
• Signs of shock
• Chest pain suggesting myocardial ischemia
• Acute heart failure symptoms

Critical caveat: If the tachycardia is regular with narrow QRS complex, consider adenosine first even in unstable patients, as it may avoid sedation and cardioversion 1. Recent prehospital data from 2025 suggests adenosine may be safely attempted first in unstable SVT before proceeding to cardioversion, with a propensity-weighted analysis showing cardioversion had an odds ratio of 2.41 for successful conversion in unstable patients 2.

Hemodynamically Stable Patients

Cardioversion is indicated when:

• Pharmacological therapy (adenosine, diltiazem, verapamil, beta-blockers) fails to restore sinus rhythm
• Pharmacological therapy is contraindicated
• Patient preference after discussion of options

Do not cardiovert if SVT is spontaneously terminating and reinitiating 1.

Energy Settings

While the ACC/AHA/HRS guidelines do not specify exact joule settings for SVT cardioversion, research evidence provides clear recommendations:

For Atrial Flutter/Atrial Tachycardia:

• Initial energy: 50 J (biphasic waveform)
• Rescue shock if needed: 250 J 3

For Atrial Fibrillation (if present):

• Duration ≤2 days: Initial 100 J
• Duration >2 days: Initial 150 J
• Rescue shock if needed: 360 J 3

For AVNRT/AVRT:

• Guidelines state cardioversion is "highly effective" but don't specify starting energy 1
• Based on the principle of using lowest effective energy, start at 50-100 J for narrow-complex SVT

Use synchronized mode to avoid delivering shock during the vulnerable period of ventricular repolarization, which could precipitate ventricular fibrillation 1.

Sedation Regimen

Adequate sedation or anesthesia is mandatory for hemodynamically stable patients undergoing cardioversion 1. The guidelines emphasize this requirement but do not specify particular agents.

Practical Sedation Approach:

• Procedural sedation with agents such as:

  • Propofol (preferred for rapid onset/offset)
  • Midazolam with fentanyl
  • Etomidate (if hemodynamic concerns)

• Ensure:

  • Continuous monitoring (ECG, pulse oximetry, blood pressure)
  • Airway equipment immediately available
  • Reversal agents accessible
  • NPO status considered (balance urgency vs aspiration risk)

For unstable patients: Cardioversion takes priority over deep sedation; use minimal sedation or proceed without if patient is obtunded 1.

Critical Warnings

Post-Cardioversion Complications:

• Atrial or ventricular premature complexes commonly occur immediately after cardioversion and may reinitiate SVT 1
• Have antiarrhythmic drugs ready to prevent acute reinitiation
• Continuous ECG monitoring essential

Pre-Excited Atrial Fibrillation:

This is a medical emergency requiring immediate cardioversion if unstable 1. The wide, irregular, rapid QRS complexes can degenerate into ventricular fibrillation. Do not use AV nodal blocking agents (adenosine, calcium channel blockers, beta-blockers, digoxin) as they may accelerate ventricular rate and precipitate VF.

Equipment Readiness:

Electrical cardioversion equipment must be immediately available whenever adenosine is administered, as adenosine can precipitate atrial fibrillation with rapid ventricular conduction 1.

Treatment Algorithm

1. Assess hemodynamic stability (mental status, blood pressure, perfusion, heart failure signs)

2. If unstable:

   • Consider adenosine if narrow-complex regular rhythm
   • If adenosine fails/not feasible → immediate synchronized cardioversion
   • Minimal sedation as tolerated
   • Start 50-100 J, escalate as needed

3. If stable:

   • Vagal maneuvers first
   • Adenosine 6 mg rapid IV push (12 mg if no response)
   • If fails → IV diltiazem, verapamil, or beta-blockers
   • If pharmacotherapy fails/contraindicated → synchronized cardioversion with adequate sedation

4. Post-cardioversion:

   • Monitor for reinitiation
   • Consider antiarrhythmic prophylaxis if recurrent
   • Refer to electrophysiology for definitive management

The success rate for cardioversion in SVT exceeds 80-99% across studies 1, 2, 4, making it highly reliable when indicated.